XML 32 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Health Care Costs Payable
3 Months Ended
Mar. 31, 2023
Health Care and Other Insurance Liabilities [Abstract]  
Health Care Costs Payable Health Care Costs Payable
The following table shows the components of the change in health care costs payable during the three months ended March 31, 2023 and 2022:
Three Months Ended
March 31,
In millions20232022
Health care costs payable, beginning of the period$10,142 $8,678 
Less: Reinsurance recoverables
Less: Impact of discount rate on long-duration insurance reserves (1)
— 
Health care costs payable, beginning of the period, net10,129 8,670 
Add: Components of incurred health care costs
  Current year21,068 18,504 
  Prior years(693)(676)
Total incurred health care costs (2)
20,375 17,828 
Less: Claims paid
  Current year11,957 10,225 
  Prior years7,645 6,183 
Total claims paid19,602 16,408 
Add: Premium deficiency reserve— 13 
Other (3)
— (13)
Health care costs payable, end of the period, net10,902 10,090 
Add: Reinsurance recoverables
Add: Impact of discount rate on long-duration insurance reserves (1)
(12)
Health care costs payable, end of the period$10,895 $10,105 
_____________________________________________
(1)Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive loss on the unaudited condensed consolidated balance sheets. Refer to Note 1 ‘‘Significant Accounting Policies’’ for further information related to the adoption of the long-duration insurance contracts accounting standard.
(2)Total incurred health care costs for the three months ended March 31, 2023 and 2022 in the table above exclude $22 million and $21 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and $51 million and $61 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets. The incurred health care costs for the three months ended March 31, 2022 also exclude $13 million for a premium deficiency reserve related to the Company’s Medicaid products.
(3)As a result of the divestiture of the international health care business domiciled in Thailand (“Thailand business”), the net assets associated with this business were accounted for as assets held for sale and the associated health care costs payable balance was included in accrued expenses on the unaudited condensed consolidated balance sheet at March 31, 2022.

The Company’s estimates of prior years’ health care costs payable decreased by $693 million and $676 million, respectively, in the three months ended March 31, 2023 and 2022, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company’s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.

At March 31, 2023, the Company’s liabilities for the ultimate cost of (i) services rendered to the Company’s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, “IBNR”) plus expected development on reported claims totaled approximately $8.0 billion. The majority of the Company’s liabilities for IBNR plus expected development on reported claims at March 31, 2023 related to the current year.